Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2012
11/01/2012US20120278953 Quantitative Trait Loci Associated With Soybean Cyst Nematode Resistance and Uses Thereof
11/01/2012US20120278952 Polypeptides having Xylanase Activity and Polynucleotides Encoding Same
11/01/2012US20120278951 Modified oil encapsulating proteins and uses thereof
11/01/2012US20120278950 Enhanced transformation of recalcitrant monocots
11/01/2012US20120278949 Shine clade of transcription factors and their use
11/01/2012US20120278948 Transgenic plant having increased biomass and improved environmental stress resistance, and process for production thereof
11/01/2012US20120278947 Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
11/01/2012US20120278946 Isolation of proteins involved in posttranscriptional gene silencing and methods of use
11/01/2012US20120278929 miRNA396 AND GROWTH REGULATING FACTORS FOR CYST NEMATODE TOLERANCE IN PLANTS
11/01/2012US20120278914 Methods and compositions for regulating production of proanthocyanidins
11/01/2012US20120278913 Ribozyme Effector Gene in Dengue Fever Transmission and Disease Control
11/01/2012US20120278912 Genetic suppression and replacement
11/01/2012US20120278911 Transgenic animal overexpressing luciferase and preparation method thereof
11/01/2012US20120278909 Compositions and methods for determining genetic polymorphisms in the tmem216 gene
11/01/2012US20120277453 Recombinant Microalgae Cells Producing Novel Oils
11/01/2012US20120277451 Diacylglycerol acyltransferase genes and use thereof
11/01/2012US20120277412 Anti-cd14 antibody fusion protein
11/01/2012US20120277410 Dehydrin-based entropic bristle domain sequences and their use in recombinant protein production
11/01/2012US20120277292 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277285 Control of gene expression
11/01/2012US20120277281 Polynucleotides for medical use
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277148 Insulin analogues with chlorinated amino acids
11/01/2012US20120277144 Novel compounds for modulating neovascularisation and methods of treatment using these compounds
11/01/2012US20120277143 IL4/IL13 Binding Repeat Proteins and Uses
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120277120 Methods for genomic modification
11/01/2012US20120277111 MicroRNA Mediated Neuronal Cell Induction
11/01/2012US20120276640 Polypeptides Having Cellobiohydrolase Activity And Polynucleotides Encoding Same
11/01/2012US20120276639 Genetically engineered recombinant escherichia coli producing l-tryptophan having originally l-phenylalanine productivity, and method for producing l-tryptophan using the microorganism
11/01/2012US20120276638 Methods of Improving the Introduction of DNA Into Bacterial Cells
11/01/2012US20120276637 Genetically engineered cyanobacteria
11/01/2012US20120276636 Method for improving induced pluripotent stem cell generation efficiency
11/01/2012US20120276635 Fluidic device
11/01/2012US20120276623 Dna removal in target molecule purification
11/01/2012US20120276613 Modified vaccinia ankara virus variant and cultivation method
11/01/2012US20120276611 Recombinantly modified plasmin
11/01/2012US20120276610 Isolation of A Protein Responsible For Uranium (VI) Reduction
11/01/2012US20120276600 Process For Preparing Dipeptidyl Peptidase IV Inhibitors And Intermediates Therefor
11/01/2012US20120276599 Ketoreductase polypeptides for the production of (r)-3-hydroxythiolane
11/01/2012US20120276594 Cellobiohydrolase variants
11/01/2012US20120276591 Compositions and Methods for Use for Antibodies Against Sclerostin
11/01/2012US20120276590 Recombinant silkworm and silkworm protein comprising heterologous protein produced by the recombinant silkworm
11/01/2012US20120276588 Use Of Galerina Marginata Genes And Proteins For Peptide Production
11/01/2012US20120276586 Desmosterol-producing yeast strains and uses thereof
11/01/2012US20120276579 Organic compounds
11/01/2012US20120276573 Nanotube structures, methods of making nanotube structures, and methods of accessing intracellular space
11/01/2012US20120276572 Methods and compositions for identifying and validating modulators of cell fate
11/01/2012US20120276567 Talaromyces transformants
11/01/2012US20120276554 Isolation and use of ryanodine receptors
11/01/2012US20120276553 Mesenchymal precursor cell
11/01/2012US20120276548 Multimer glycosylated nucleic acid binding protein conjugates and uses thereof
11/01/2012US20120276540 Method and probe set for detecting cancer
11/01/2012US20120276537 Homologous recombination in the oocyte
11/01/2012US20120276532 Sample processing device for pretreatment and thermal cycling
11/01/2012US20120276528 Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
11/01/2012US20120276247 Lipase Variants
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276147 Ctsp cancer-testis antigens
11/01/2012US20120276146 Vaccine against cholera and enterotoxigenic e. coli (etec) diarrhea
11/01/2012US20120276144 Pro-Apoptotic Bacterial Vaccines To Enhance Cellular Immune Responses
11/01/2012US20120276142 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same
11/01/2012US20120276132 Atoxic recombinant holotoxins of Clostridium difficile as immunogens
11/01/2012US20120276131 Anti-trypanosomiasis vaccines and diagnostics
11/01/2012US20120276129 Neisserial antigenic peptides
11/01/2012US20120276125 Novel immunoconjugates
11/01/2012US20120276117 Binding Partners for the Thyrotropin Receptor and Uses Thereof
11/01/2012US20120276116 Prevention and Treatment of Amyloidogenic Disease
11/01/2012US20120276114 Ifn-gamma inhibitors in the treatment of motoneuron diseases
11/01/2012US20120276112 Anti-factor xi monoclonal antibodies and methods of use thereof
11/01/2012US20120276099 Monospecific polypeptide reagents
11/01/2012US20120276098 Drug fusions and conjugates with extended half life
11/01/2012US20120276097 Immunoglobulin fusion proteins
11/01/2012US20120276096 Immunoglobulin fusion proteins
11/01/2012US20120276090 Gene recombinant antibody and antibody fragment thereof
11/01/2012US20120276078 Glycosidase enzymes
11/01/2012US20120276074 Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
11/01/2012US20120276073 Treatment of nerve injuries
11/01/2012US20120276072 Constructs for expressing lysosomal polypeptides
11/01/2012US20120276071 Anti-HIV Group I Introns and Uses Thereof in Treating HIV Infections
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120276046 Anti ganglioside gd3 antibodies and uses thereof
11/01/2012US20120276043 Immunoglobulin fusion proteins
11/01/2012US20120276012 Method of Treatment and Screening Method
11/01/2012US20120276010 Microorganisms for therapy
11/01/2012US20120276009 Pharmaceutical composition
11/01/2012US20120275997 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834624A1 Il4/il13 binding repeat proteins and uses
11/01/2012CA2834430A1 Composition and method for predicting response to trastuzumab therapy in breast cancer patients
11/01/2012CA2834404A1 Anti-cd40 antibodies and methods of use
11/01/2012CA2834376A1 Neutralizing antibodies to nipah and hendra virus
11/01/2012CA2834375A1 Methods for genomic modification
11/01/2012CA2834333A1 Method for controlling weeds in a field of cotton plants
11/01/2012CA2834291A1 Methods and compositions for nucleic acid analysis
11/01/2012CA2834266A1 Method for controlling weeds in a field of cotton plants
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2834215A1 Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 4023